Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.

J Clin Psychiatry. 2012 May;73(5):654-60. doi: 10.4088/JCP.11m07522. Erratum in: J Clin Psychiatry. 2012 Jul;73(7):1035.

PMID:
22697191
2.

Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.

Pachas GN, Cather C, Pratt SA, Hoeppner B, Nino J, Carlini SV, Achtyes ED, Lando H, Mueser KT, Rigotti NA, Goff DC, Evins AE.

J Dual Diagn. 2012;8(2):117-125.

3.

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.

Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S.

Circulation. 2010 Jan 19;121(2):221-9. doi: 10.1161/CIRCULATIONAHA.109.869008.

4.

The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial.

Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, Brauer R, Kessler PD, Kalnik MW, Fahim RE, van Schayck OC.

BMC Public Health. 2012 Dec 6;12:1052. doi: 10.1186/1471-2458-12-1052.

5.

[Effectiveness and safety of varenicline for smoking cessation].

Christalla P, Dewenter M, El-Armouche A.

Dtsch Med Wochenschr. 2012 May;137(18):940-4. doi: 10.1055/s-0032-1304895. Review. German.

PMID:
22492478
6.

Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.

Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, McFarland N, Thabane L, McIvor A, Zeidler J, Smieja M.

AIDS Patient Care STDS. 2012 Jan;26(1):12-9. doi: 10.1089/apc.2011.0199.

7.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
9.

Safety of varenicline among smokers enrolled in the lung HIV study.

Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, Wewers ME.

Nicotine Tob Res. 2013 Jan;15(1):247-54. doi: 10.1093/ntr/nts121.

10.

A double-blind study evaluating the long-term safety of varenicline for smoking cessation.

Williams KE, Reeves KR, Billing CB Jr, Pennington AM, Gong J.

Curr Med Res Opin. 2007 Apr;23(4):793-801.

PMID:
17407636
11.

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.

Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.

Arch Intern Med. 2006 Aug 14-28;166(15):1571-7.

PMID:
16908789
12.
14.
15.

Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study.

Kasliwal R, Wilton LV, Shakir SA.

Drug Saf. 2009;32(6):499-507. doi: 10.2165/00002018-200932060-00006.

PMID:
19459717
16.

Varenicline: cardiovascular safety.

Samuels L.

CMAJ. 2011 Sep 6;183(12):1407-8; author reply 1408. doi: 10.1503/cmaj.111-2073. No abstract available.

17.

The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.

Poling J, Rounsaville B, Gonsai K, Severino K, Sofuoglu M.

Am J Addict. 2010 Sep-Oct;19(5):401-8. doi: 10.1111/j.1521-0391.2010.00066.x.

18.

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD.

Patient Prefer Adherence. 2010 Oct 5;4:355-62.

19.

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial.

Niaura R, Hays JT, Jorenby DE, Leone FT, Pappas JE, Reeves KR, Williams KE, Billing CB Jr.

Curr Med Res Opin. 2008 Jul;24(7):1931-41. doi: 10.1185/03007990802177523 .

PMID:
18513462
20.

The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey.

Enger C, Younus M, Petronis KR, Mo J, Gately R, Seeger JD.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):705-15. doi: 10.1002/pds.3400.

PMID:
23349095
Items per page

Supplemental Content

Support Center